Olumiant
Drug timelines are a Plus or Pro feature.
14 regulatory and trial events tracked for Olumiant, covering 2017-04-21 to 2026-04-10. Get the full timeline:
Most recent: EMA Authorised: Olumiant (Baricitinib) — Eli Lilly Nederland B.V.
14 regulatory and trial events tracked for Olumiant, covering 2017-04-21 to 2026-04-10. Get the full timeline:
Most recent: EMA Authorised: Olumiant (Baricitinib) — Eli Lilly Nederland B.V.